06.06.08
Patheon
2Q Revenues: $186 million (16%)
2Q Loss: $8.5 million (loss of $22 million in 2Q07)
YTD Revenues: $350 million (+14%)
YTD Loss: $23.7 million (loss of $24 million YTD07)
Comments: Commercial manufacturing revenues in the quarter increased 15% to $151.2 million driven by strong growth in Europe particularly in Bourgoin-Jallieu, France and growth in North America led by Whitby. Pharmaceutical Development Services revenues increased 23% to $34.8 million, with growth in both North America and Europe. Total North American revenues YTD08 increased 3% and European revenue increased 30%.
2Q Revenues: $186 million (16%)
2Q Loss: $8.5 million (loss of $22 million in 2Q07)
YTD Revenues: $350 million (+14%)
YTD Loss: $23.7 million (loss of $24 million YTD07)
Comments: Commercial manufacturing revenues in the quarter increased 15% to $151.2 million driven by strong growth in Europe particularly in Bourgoin-Jallieu, France and growth in North America led by Whitby. Pharmaceutical Development Services revenues increased 23% to $34.8 million, with growth in both North America and Europe. Total North American revenues YTD08 increased 3% and European revenue increased 30%.
